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Myocardial Mechanics in Hyperthyroidism: Importance of Left 
Ventricular Loading Conditions, Heart Rate and Contractile State 
TED FELDMAN, MD, KENNETH M. BOROW, MD, FACC, DAVID H. SARNE, MD, 
ALEX NEUMANN, BS, ROBERTO M. LANG, MD 
Chicago. lllinois 
Hyperthyroidism has been reported to affect all of the 
major determinants of left ventricular performance in 
a manner that would augment ventricular shortening 
characteristics. The hypothesis tested in this study is that 
reduced afterload in conjunction with increased preload 
and heart rate, rather than augmented contractility, ac•
counts for much of the increase in left ventricular per•
formance noted previously in these patients. To inves•
tigate this hypothesis, 11 hyperthyroid patients were 
evaluated serially over 4 ± 2 months. With therapy, 
serum total thyroxin (T 4) decreased significantly (p < 
0.001). Ventricular hemodynamics were assessed by two•
dimensionlll targeted M-mode echocardiograms and cal•
ibrated carotid pulse tracings. Ventricular preload was 
estimated by end-diastolic dimension, whereas afterload 
was measured as end-systolic wall stress. Overall left 
ventricular performance was quantitated by the extent 
and velocity of shortening, whereas myocardial work 
was assessed by ventricular systolic stress-length rela•
tiohs. 
Overall left ventricular performance reflects the net inter•
action of preload, afterload, heart rate and contractility. It 
is generally believed that hyperthyroidism affects all of these 
factors in a manner that enhances ventricular shortening 
characteristics (1-7). This is based on the fact that total 
plasma volume (8) (and presumably ventricular preload), 
heart rate and contractility are augmented whereas afterload 
(as measured by systemic vascular resistance) is reduced 
(5,7). Previous clinical studies of hyperthyroidism have used 
traditional ejection phase indexes (for example. ejection 
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With therapy, overall left ventricular performance 
declined (p < 0.0]). This change was associated with no 
change in end-diastolic dimension or end-systolic wall 
stress, and a 24% fall in heart rate (p < 0.01). This 
latter finding has been shown previously to have no sig•
nificant effect on left ventricular contractile state over 
the range of heart rates encountered in this study. In all 
cases, the end-systolic stress/rate-corrected shortening 
velocity relation fell with attainment of normal thyroid 
status, characteristic of a decline in contractility. There 
was a strong positive correlation between left ventricular 
contractility and serum thyroid hormone level (r = 0.83). 
In addition, ventricular minute work declined with ther•
apy (p < 0.01). Thus, the hyperkinesia of hyperthy•
roidism in humans is due to augmented contractility 
rather than altered loading or chronotropic conditions. 
(J Am Coli CardioI1986;7:967-74) 
fraction, shortening fraction and systolic time intervals) to 
assess changes in overall left ventricular performance. Un•
fortunately, these indexes are unable to separate thyroid 
hormone-induced alterations in ventricular contractility that 
have been demonstrated in isolated muscle (9,10) from 
changes in preload, afterload and heart rate in patients with 
hyperthyroidism (2,5,7,11-13). In addition, the relative 
contribution of each of these factors to the augmented myo•
cardial mechanics in humans with hyperthyroidism has yet 
to be established. 
Recently, several noninvasively determined indexes of 
ventricular function have been shown to be clinically useful 
in the assessment of subtle abnormalities in left ventricular 
contractile state (14-16). The most promising of these is 
the relation between left ventricular end-systolic wall stress 
and rate-corrected velocity of fiber shortening (15). This 
index is independent of preload. incorporates afterload, heart 
rate and left ventricular mass and is sensitive to alterations 
in left ventricular contractile state (15). 
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The purpose of this study was to determine the effects 
of clinical hyperthyroidism on left ventricular mechanics in 
humans. The specific questions addressed included: 1) What 
is the contribution of altered loading conditions and heart 
rate to overall left ventricular performance in hyperthyroid•
ism? 2) What is the effect of hyperthyroidism on left ven•
tricular contractile state, myocardial oxygen consumption 
and cardiac work, and how are these affected by therapy? 
3) How well do standard thyroid function tests correlate 
with changes in left ventricular contractility? 
Methods 
Study patients. Eleven patients with hyperthyroidism 
secondary to Graves' disease (1 male, lO female; mean age 
34 ± 13 years) who presented to the endocrine clinic of 
the University of Chicago were evaluated. In addition to 
typical clinical signs and symptoms, the diagnosis was con•
firmed by the presence of elevated serum thyroxine (T 4) 
(mean 21 ± 6 /-Lg/dl [p < 0.001]; range 13 to 32; normal 
range 5 to 12), serum triiodothyronine (T3) (mean 378 ± 
117 ng/dl [p < 0.001]; range 229 to 624; normal range 70 
to 175) and free thyroxine index (mean 27 ± 7 [p < 0.001]; 
range 15 to 36; normal range 6 to 10. Serum thyroxine and 
triiodothyronine were determined by radioimmunoassay and 
the free thyroxine index was calculated as the product of 
the serum thyroxine and a normalized resin thyroxine uptake 
(17). The time interval from onset of symptoms to the first 
echocardiographic examination was 5 ± 3 months (range 
2 to 12). Patients were excluded from the study if they 1) 
had known cardiovascular disease not related to hyperthy•
roidism (for example, history of myocardial infarction or 
ventricular arrhythmia), 2) were receiving beta-adrenergic 
blocking agent therapy, or 3) demonstrated left ventricular 
regional wall motion abnormalities on screening two-di•
mensional echocardiographic examination. All study pa•
tients were initially treated with propylthiouracil. This was 
followed by subtotal thyroidectomy in five patients and treat•
ment with iodine-131 in two patients. All patients had sinus 
rhythm throughout the study period. Results were compared 
with data obtained from 11 age-matched (34 ± 12 years) 
normal control subjects. Written informed consent was ob•
tained according to a protocol approved by the Clinical 
Investigation Committee of The University of Chicago Hos•
pitals and Clinics. 
Experimental protocol. The experimental protocol has 
been described previously in detail (14-16). Simultaneous 
recordings of the two-dimensional targeted M-mode echo•
cardiogram (Hewlett-Packard Ultrasound Imager), phono•
cardiogram, electrocardiogram, indirect carotid pulse trac•
ing and blood pressure measurements were performed under 
baseline hyperthyroid conditions. Repeat studies were done 
approximately 7, 21, 35 and 49 days after initiation of 
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therapy. Measurements of serum thyroxine and free thy•
roxine index were made at the time of each of these studies. 
Recordings and measurements. Peak systolic, dia•
stolic and mean arterial blood pressure determinations were 
made with the Dinamap 1846P Vital Signs Monitor (Cri•
tikon). This device has been shown to accurately estimate 
central aortic pressures over a wide range of values inde•
pendent of the patient's cardiac index, systemic vascular 
resistance, left ventricular ejection fraction and body surface 
area (18). Left ventricular end-systolic and end-diastolic 
dimensions (Des- Ded) and wall thicknesses (he" hed) were 
measured from the echocardiographic recordings as previ•
ously described (14-16). Left ventricular mass index (LVMI) 
was calculated according to a modification of the method 
of Devereux et al. (19): 
LVMI = 1.04 [(Ded + 2hed)3 - (Ded)3] 
- 13.6/body surface area. 
Total systemic resistance was calculated as mean arterial 
pressure divided by the echocardiographically derived car•
diac output and converted to dynes.cms - 5 (20). This as•
sumes that the left ventricle contracts in a symmetric man•
ner, a finding confirmed for each subject in our study by 
two-dimensional echocardiographic imaging. The left ven•
tricular percent fractional shortening (%AD) was calculated 
as end-diastolic dimension minus end-systolic dimension 
divided by end-diastolic dimension. The left ventricular end•
systolic pressure was estimated by linear interpolation to 
the height of the incisura using a calibrated carotid pulse 
tracing (18). The left ventricular ejection time (LVET) was 
measured from the carotid pulse tracing in the standard 
manner (21). The rate-corrected left ventricular mean ve•
locity of fiber shortening (Vcfc) was calculated as: 
%AD %AD ,~ 
Vcfc = - (vRR) L VETVRR - L VET ' 
where %AD = percent change in ventricular dimension and 
RR = the interval between cardiac cycles as determined 
from the electrocardiogram (15). 
Three to five cardiac cycles for each M-mode echocar•
diographic recording were digitized using a Franklin Quan•
tic 1200 off-line data analysis system (Bruce Franklin, Inc.). 
This device has a digitizing pad with a sampling rate of 
80/cm (400/s). The Quantic 1200 is programmed to correct 
for pulse transmission time by aligning the dicrotic notch 
of the carotid pulse tracing with the first high frequency 
component of the aortic component of the second heart 
sound. Left ventri<::ular meridional wall stress (a) was cal•
culated using the angiographically validated formula (22): 
(P)(D)(l.35) 
a= 
(h)[l + (hlD)](4), 
where ais in g/cm2; P (pressure) is in mm Hg; D (dimension) 
and h (thickness) are in cm; and 1.35 is the factor to convert 
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Pe, (end-systolic pressure) from mm Hg to g/cm2, Peak 
systolic and end-systolic wail stresses were calculated. Mean 
wall stress during left ventricular ejection was calculated as 
the average of instantaneous wall stress values from onset 
to end-ejection, Stress-time and stress-dimension plots cal•
culated by the Quantic 1200 were digitized. Left ventricular 
stress-time (g.s/cm2) and systolic stroke work indexes (g/cm 
per m2 body surface area) were calculated as the integral of 
the instantaneous stress-time and stress-dimension plots, re•
spectively, from onset to end-ejection, Both indexes were 
multiplied by heart rate, giving left ventricular stress-time 
per minute and left ventricular minute work index. 
Statistical analysis. Paired t tests were performed to 
compare maximal pretreatment and minimal posttreatment 
values. An unpaired t test was used to compare normal 
control subjects with patients before and after therapy and 
the Bonferroni correction was used for these multiple com•
parisons, A probability (p) value of less than 0.05 was 
considered statistically significant. Correlations between the 
serial thyroid function studies and the end-systolic indexes 
of left ventricular contractility were determined. The cor•
relation coefficients were calculated by least squares linear 
regression analysis. Group data are expressed as mean val•
ues ± standard deviation, 
Results 
Clinical course. The mean duration of follow-up was 4 
± 2 months (Fig. 1). Serum total thyroxine (T4 ) decreased 
from 21 ± 6 to 5 ± 3 /Lg/dl (p < 0.001) whereas free 
thyroxine index decreased from 27 ± 7 to 5 ± 3 (p < 
0.001). Patients pretreated with propylthiouracil were clin•
ically and biochemically euthyroid before undergoing sur•
gery. All patients became euthyroid within 8 weeks of ini•
tiation of treatment. 
Left ventricular hemodynamics (Table 1). Left ven•
tricular hemodynamics obtained in the study patients before 
and after therapy were compared with values from the age•
matched normal subjects. The major disparities between the 
control and pretreatment values reflected differences in left 
ventricular ejection phase indexes and heart rates. In con•
trast, there were no hemodynamic differences between the 
control and posttreatment data. There were no significant 
changes in peak systolic, end-systolic, diastolic or mean 
aortic pressures between the groups. When pre- and post•
treatment values were compared, heart rate declined by 24% 
from 91 ± 16 beats/min before therapy to 69 ± 13 after 
therapy (p < 0.0l) (Fig. 2, top). Although left ventricular 
end-diastolic dimension (a measure of preload) did not change 
after therapy (Fig. 2, bottom), left ventricular end-systolic 
dimension increased by 7% (p < 0.05). With therapy the 
rate-corrected ejection time increased by 6% (p < 0.05) and 
cardiac output fell by one-third (p < 0.05). This resulted 
in a 32% increase in total systemic resistance (an index of 
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Figure 1. Plot of individual patients' response to therapy. Both 
total thyroxine (T 4) and free thyroxine index decreased signifi-
cantly. Six patients became biochemically hypothyroid during ther-
apy. PRE RX and POST RX = before and after treatment, re-
spectively. 
peripheral vascular tone). During the course of treatment, 
end-systolic wall stress (a measure of left ventricular after•
load) did not change significantly. In addition, there were 
no changes in mean or peak wall stress, ventricular wall 
mass index or systolic stress-time index per minute. In con•
trast, total left ventricular minute work index declined by 
37% (8,743 ± 2,004 versus 5,478 ± 1,629 g-crnlm2; p < 
0.01). The net effect on overall left ventricular performance 
(Fig. 3) was a 14% decline in percent fractional shortening 
and an 18 % fall in rate-corrected shortening velocity (p < 
0.01 for both). 
Left ventricular end-systolic stress/velocity of short•
ening relation. Figure 4 compares the relation between 
end-systolic wall stress and rate-corrected velocity of fiber 
shortening for the study group with the previously published 
mean (± 2 SD) value for this relation generated from a 
normal population over a wide range of end-systolic stresses 
(15). In all cases initially increased contractility declined 
significantly with therapy. There is no overlap of rate-cor-
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Table 1. Summary of Hemodynamic Data in II Patients 
Before 
Control Therapy 
HR (beats/min) 71 ± 13 91 ± 16 
Pp, (mm Hg) 122 ± 10 129 ± 16 
Pm (mm Hg) 86 ± 8 89 ± 12 
Pe, (mm Hg) 101 ± 10 98 ± 13 
Oed (cm) 4.79 ± 0.30 4.70 ± 0.48 
De, (cm) 3.22 ± 0.23 2.98 ± 0.40 
CO (liters/min) 4.5 ± 0.7 6.2 ± 1.8 
SVR (dyne's-cm- 5) 1,546 ± 256 1,228 ± 321 
LVET (ms) 300 ± 30 251 ± 24 
ETc (ms) 318 ± 23 307 ± 20 
U e, (g/cm2) 49 ± 10 47 ± 9 
uP' (g/cm2) 144 ± 28 137 ± 19 
U m (g/cm2) 97 ± 15 92 ± 15 
%aD 33 ± 4 37 ± 3 
Vcf (circ/s) 1.11 ±0.13 1.47 ± 0.19 
Vcfc (circ/s) 1.04 ± 0.14 1.20 ± 0.08 
L V mass index (g/ml) 105 ± 23 99 ± 25 
STI (g.s/cml) 28 ± 5 22 ± 5 
MSTI (g.s/cm2 per min) 1,943 ± 414 2,042 ± 474 
MWI (g/cm per ml) 6,544 ± 1.221 8.743 ± 2,004 
Control 
vs. Before 
After Therapy Therapy 
69 ± 13 < 0.05 
122 ± II NS 
88 ± 9 NS 
95 ± II NS 
4.68 ± 0.56 NS 
3.20 ± 0.47 NS 
4.1 ± 1.1 < 0.05 
1,813 ± 427 NS 
306 ± 22 < 0.01 
325 ± 25 NS 
55 ± 14 NS 
136 ± 26 NS 
95 ± 19 NS 
32 ± 3 < 0.05 
1.04 ± 0.11 < 0.01 
0.98 ± 0.06 < 0.05 
100 ± 29 NS 
27 ± 7 < 0.01 
1.785 ± 366 NS 
5,478 ± 1,629 < 0.01 
p Values* 
Before 
vs. After 
Therapy 
< 0.01 
NS 
NS 
NS 
NS 
< 0.05 
< 0.05 
< 0.01 
< 0.01 
< 0.05 
NS 
NS 
NS 
< 0.01 
< 0.01 
< 0.01 
NS 
NS 
NS 
< 0.01 
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Control 
vs. After 
Therapy 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
*Corrected for multiple comparisons. CO = cardiac output; Oed and De' = end-dIastolic and end-systolic dimension, respectively; %aD = percent 
shortening fractIOn; ETc = rate-corrected ejection time; HR = heart rate; L VET = left ventncular ejection time; MSTI = wall stress-time index per 
minute; MWI = minute work index; Pp,' Pm and Pe, = peak. mean and end-systolic pressure, respectIvely; STI = wall stress-time index; SVR = total 
systemic resistance; uP" U m and U e, = peak, mean and end-systolic wall stress. respectIvely; Vcf and Vcfc = shortening velocity and rate-corrected 
shortemng velocity, respectively. 
rected shortening velocity for the two groups. On an indi•
vidual basis, 8 of II patients had pretreatment end-systolic 
stress/rate-corrected shortening velocity points that ex•
ceeded the 2 standard deviation confidence limits; all points 
were above the mean regression line for the normal popu•
lation. For any end-systolic stress/rate-corrected shortening 
velocity point the vertical distance to the mean regression 
line represents the deviation from the predicted rate-cor•
rected shortening velocity at that level of end-systolic wall 
stress. The resultant difference (that is, actual minus pre•
dicted rate-corrected shortening velocity) is an index of left 
ventricular contractility that is independent of ventricular 
heart rate and loading conditions. Each point may also be 
described in terms of standard deviation units from the mean 
regression line. The group mean for the study patients fell 
with therapy from a value that was greater than 2 standard 
deviation units above the mean regression line to just below 
this line. 
To assess the effect of thyroid hormone on myocardial 
contractility, the relation between thyroid hormone levels 
and deviation from the mean normal end-systolic stress/rate•
corrected shortening velocity regression line was determined 
using all of the serial studies (n = 52) obtained from the 
patient group (Fig. 5). Free thyroxine index correlated strongly 
(r = 0.83) with contractile state over a wide range of values. 
The correlation coefficient for total serum thyroxine was 
also highly positive (r = 0.77). 
Discussion 
This study used left ventricular force-shortening-velocity 
characteristics to define myocardial mechanics before and 
after therapy in patients with hyperthyroidism. The follow•
ing discussion addresses the effects of preload, afterload, 
contractility and heart rate on overall left ventricular per•
formance and myocardial oxygen requirements in these pa•
tients. 
Preload. In spite of the increase in total body plasma 
volume known to accompany hyperthyroidism (8), our sub•
jects did not show a change in left ventricular end-diastolic 
dimension with therapy. This suggests that preload is not 
an important determinant of the augmented ventricular per•
formance in hyperthyroidism. Furthermore, it suggests that 
total body plasma volume and left ventricular preload are 
not synonymous. 
Afterload. Total systemic vascular resistance increased 
as patients became euthyroid. Previous investigators have 
found similar changes (3,7,23). Interestingly, the rise in 
total systemic resistance (a measure of peripheral arterial 
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Figure 2. Plot of heart rate and left ventricular end-diastolic di•
mensions for individual patients. Heart rate declined 24% with 
treatment for hyperthyroidism. There was no change in end-dia•
stolic dimension, a measure of left ventricular preload. Abbrevi•
ations as in Figure 1. 
tone) in our study was not associated with changes in left 
ventricular afterload as measured by end-, peak or mean 
systolic wall stress. This means that afterload reduction is 
not responsible for the hyperdynamic state associated with 
untreated hyperthyroidism. This is an example of disparity 
between peripheral vascular tone and the forces acting on 
myocardial fibers (that is, afterload) and reflects differences 
between the peripheral and cardiac effects of thyroid hor•
mone (24). 
In this study, no change was noted in left ventricular 
mass. Reversible cardiac hypertrophy induced by thyroid 
hormone has been reported in animals, but left ventricular 
mass increased above the normal range has yet to be dem•
onstrated in adult humans (25-27). Changes in myocardial 
protein synthesis induced in animals by thyroid hormone 
administration have not yet been found in humans. 
Contractility. There was a strong positive correlation 
between thyroid hormone levels and myocardial contractil•
ity, measured as deviation of the end-systolic stress-rate 
corrected velocity of fiber shortening relation from its nor-
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Figure 3. Left ventricular shortening characteristics (percent frac•
tional shortening and heart rate-corrected velocity of shortening 
[Vcf]) decreased significantly with the change from the hyperthy•
roid to the treated state. Abbreviations as in Figure 1. 
mal mean regression line (Fig. 5). This finding is consistent 
with a shift in the force-velocity curve upward and to the 
right noted previously in isolated cat papillary muscle treated 
with thyroxine (9). Because our data were acquired over a 
mean of 4 ± 2 months at multiple stages of therapy, they 
suggest that left ventricular contractile state correlates closely 
and in a temporal manner with the patient's biochemical 
thyroid hormone profile (28). 
Heart rate. With antithyroid therapy, heart rate fell from 
91 ± 16 to 69 ± 13 beats/min. It is important to consider 
how this magnitude of change in heart rate could influence 
left ventricular contractile state. It has been demonstrated 
that the positive inotropic effect of a steady state increase 
in cardiac frequency is less marked at physiologic than at 
room temperature, and in the intact ventricle than in isolated 
cardiac tissue (29). Also, increases in contractility appear 
to be considerably smaller in intact conscious dogs than in 
dogs in the anesthetized state (30). We recently examined 
this question in 10 normal subjects. A change in heart rate 
from 55 ± 6 to 86 ± 8 beats/min did not significantly alter 
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Figure 4. Mean (solid line) and ± 2 SD confi•
dence limits (dashed lines) for end-systolic 
stress/rate-corrected shortening velocity (Vct) re•
lation determined from a group of normal subjects 
(15). Vertical deviation from the mean regression 
line reflects a change in contractility for a given 
level of end-systolic wall stress independent of heart 
rate, preload and afterload. The end-systolic 
stresslrate-corrected shortening velocity relation for 
the 11 hyperthyroid subjects before (solid squares) 
and after (open squares) therapy is shown. Before 
treatment, values for all subjects were above the 
mean regression line, reflecting increased contrac•
tile state; 8 of the II points were above the ± 2 
SD confidence limits. After treatment, all subjects 
showed a decline in the end-systolic stress/rate-cor•
rected shortening velocity relation. One subject (value 
below the - 2 SD confidence limit [lower left]) 
was hypothyroid. Abbreviations as in Figure 1. 
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left ventricular contractilty as measured by the end-systolic 
stress-rate-corrected velocity of fiber shortening relations. 
This finding is in agreement with other studies performed 
over the physiologic range for heart rate in humans (31,32). 
Thus, chronotropic factors do not appear to have contributed 
significantly to the increased contractility associated with 
hyperthyroidism. 
Myocardial oxygen requirements. The hypermeta•
bolic state in hyperthyroidism is accompanied by increased 
myocardial oxygen consumption (5,23,33). In this study we 
used the left ventricular systolic stress-time index per minute 
to assess relative myocardial oxygen demands. This mea•
sure, which incorporates two of the three major determinants 
of myocardial oxygen consumption (systolic wall stress and 
heart rate) has been shown previously to reflect changes in 
myocardial oxygen consumption (34). The remaining major 
determinant, contractility, should account for most, if any, 
........ 
........ -25D 
100 
disparity between expected and actual myocardial oxygen 
consumption. We found that the left ventricular systolic 
stress-time index per minute did not change with therapy, 
reflecting counterbalancing effects of the 24% decrease in 
heart rate and the 23% increase in stress-time index per 
beat. The known increase in myocardial oxygen consump•
tion that occurs with hyperthyroidism must therefore be due 
predominantly either to increased demand caused by aug•
mented left ventricular contractility and external work or to 
decreased myocardial efficiency. The 60% higher values for 
left ventricular minute work index noted under pretreatment 
(that is, hyperthyroid) conditions in our patients suggest that 
increased left ventricular oxygen demand, not myocardial 
inefficiency, was the major factor. 
Methodologic considerations. It has been suggested that 
the left ventricular hyperkinesia in hyperthyroidism is me•
diated by either catecholamine excess or enhanced cate-
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Figure 5. Rate-corrected velocity of shortening (V ct) 
in SD units from the normal mean regression line 
plotted against free thyroxine index for all 52 serial 
studies obtained from the 11 patients. There is a 
strong positive correlation between the level of thy•
roid hormone and the change in contractile state. 
The shaded area represents the normal range for 
serum free thyroxine index. 
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cholamine sensitivity. Plasma catecholamine concentrations 
are normal or decreased in hyperthyroid patients, and myo•
cardial beta-adrenergic binding sites in animals are increased 
(2,26). Beta-receptor blockade with sotalol, an agent free 
of intrinsic myocardial depressant properties, abolishes the 
tachycardia and shortened circulation time in hyperthyroid•
ism, but does not change left ventricular performance (35). 
This suggests that thyroxine affects the heart independent 
of circulating catecholamines and the sympathetic nervous 
system (35). Although we did not measure serum cate•
cholamine concentrations, it does not appear that this in•
formation would significantly alter the interpretation of our 
results. 
Systemic vascular resistance was estimated using non•
invasive techniques. As afterload (measured as end-, peak 
or mean systolic stress) did not change, a difference in 
systemic resistance in either direction would not alter our 
conclusions. Echocardiographic determination of cardiac 
output in patients with a normal sized left ventricle in the 
absence of wall motion abnormalities has been shown pre•
viously to be accurate (36,37). This is particularly true when 
all subjects serve as their own control in serial studies using 
two-dimensionally targeted M-mode echocardiographic im•
aging. The direction and magnitude of change in systemic 
resistance with therapy in these patients are similar to those 
reported by other investigators (7,25). 
Conclusion. The hyperdynamic appearance of the left 
ventricle in hyperthyroidism is due to increased contractility 
independent of alterations in ventricular preload, afterload 
and heart rate. 
We thank Dina Janzen for excellent help In preparing this manuscript. as 
well as Dianne Altman and PatricIa Wolinski for assIstance in data ac•
qUIsitIOn. 
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